HbA1c reduction with tirzepatide in people with type 2 diabetes: a mediation analysis using body weight loss as a factor

被引：0
|
作者：
Vilsboll, T. [1 ]
Nicolay, C. [2 ]
Malecki, M. [3 ]
Thieu, V. Thuyanh [2 ]
Chivukula, K. [2 ]
Kiljanski, J. [2 ]
机构：
[1] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Ctr Clin Metab Res, Herlev, Denmark
[2] Eli Lilly & Co, Indianapolis, IN USA
[3] Jagiellonian Univ, Dept Metab Dis, Med Coll, Krakow, Poland
来源：
DIABETOLOGIA | 2023年 / 66卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
643
引用
收藏
页码：S324 / S325
页数：2
相关论文
共 50 条
  • [21] Achieving the composite endpoint of HbA1c, body weight, and systolic blood pressure reduction with canagliflozin in patients with type 2 diabetes
    Merton, Katherine
    Davies, Michael J.
    Vijapurkar, Ujjwala
    Inman, Doreen
    Meininger, Gary
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (02) : 313 - 318
  • [22] Canagliflozin provides greater attainment of both HbA1c and body weight reduction versus sitagliptin in patients with type 2 diabetes
    Schernthaner, Guntram
    Lavalle-Gonzalez, Fernando J.
    Davidson, Jaime A.
    Jodon, Holly
    Vijapurkar, Ujjwala
    Qiu, Rong
    Canovatchel, William
    POSTGRADUATE MEDICINE, 2016, 128 (08) : 725 - 730
  • [23] Achieving composite endpoint of HbA1c, body weight, and systolic blood pressure reduction with canagliflozin in patients with type 2 diabetes
    Merton, K.
    Davies, M. J.
    Vijapurkar, U.
    Inman, D.
    Meininger, G.
    DIABETOLOGIA, 2016, 59 : S345 - S345
  • [24] A Meta-Analysis to Quantify the Effect of Weight Reduction on HbA1c in Overweight or Obese Type 2 Diabetes Patients
    Gummesson, Anders
    Nyman, Elisabeth
    Knutsson, Mikael
    Karpefors, Martin
    DIABETES, 2013, 62 : A539 - A539
  • [25] Pramlintide, as an adjunct to premixed insulin, reduced HbA1c and body weight in patients with type 2 diabetes
    Darsow, T.
    Lorenzi, G.
    Zhang, B.
    Maier, H.
    Wilhelm, K.
    DIABETOLOGIA, 2008, 51 : S409 - S409
  • [26] In uncontrolled type 2 diabetes, adjunctive semaglutide reduced HbA1c and body weight vs sitagliptin
    Lipscombe, Lorraine L.
    ANNALS OF INTERNAL MEDICINE, 2019, 171 (04) : JC16 - JC16
  • [27] HbA1c Reduction Associated with a FreeStyle LibreSystem in People with Type 2 Diabetes Not on Bolus Insulin Therapy
    Wright, Eugene, Jr.
    Kerr, Matthew S. D.
    Reyes, Ignacio J.
    Nabutovsky, Yelena
    Miller, Eden
    DIABETES, 2020, 69
  • [28] Diabetes education lowers HbA1c and weight in a veteran population with Type 2 Diabetes
    Tacker, Deanna
    Harris, Margaret M.
    Carroll, Polly
    Hays, Nicholas
    Johnson, Pippa
    Hakkak, Reza
    FASEB JOURNAL, 2007, 21 (05): : A304 - A304
  • [29] Systolic Blood Pressure Reduction with Tirzepatide across SURPASS Program: A Mediation Analysis Using Weight Loss as a Factor
    Lingvay, Ildiko
    Mosenzon, Ofri
    Brown, Katelyn
    Cui, Xuewei
    Lando, Laura Fernandez
    Patel, Hiren
    DIABETES, 2022, 71
  • [30] Reductions in HbA1c and body weight with 2 years of exenatide treatment in overweight patients with type 2 diabetes
    Ivanyi, Tibor
    Guan, Xuesong
    Mac, Susanna
    Holcombe, John
    Blonde, Lawrence
    INTERNATIONAL JOURNAL OF OBESITY, 2007, 31 : S27 - S27
12345